Hook Group

All the posts published.

Director/PDMR Shareholding

Jun 27, 2022
-
News, RNS Announcements
  NetScientific plc Director/PDMR Shareholding NetScientific plc (AIM:NSCI) (the “Company”), the transatlantic healthcare IP commercialisation group, announced on 22 June 2022, that it had closed its Placing of 2,238,807 Placing Shares at a Placing Price of 67 pence per Placing Share.   Dr Ilian Iliev and Mr John Clarkson (each a Director of the Company) and Mr Stephen Crowe (CFO) each participated in the…

TR-1: Standard form for notification of major holdings

Jun 27, 2022
-
News, RNS Announcements
TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: NetScientific Plc 1b. Please indicate if the issuer is a non-UK issuer (please mark with…

Result of Placing and Total Voting Rights

Jun 22, 2022
-
News, RNS Announcements
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND ARE NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR…

Proposed Placing to raise at least £1.5 million

Jun 21, 2022
-
News, RNS Announcements
THE INFORMATION IN THIS ANNOUNCEMENT, WHICH INCLUDES CERTAIN INFORMATION DRAWN FROM PUBLIC SOURCES, DOES NOT PURPORT TO BE COMPREHENSIVE AND HAS NOT BEEN INDEPENDENTLY VERIFIED. THIS ANNOUNCEMENT CONTAINS STATEMENTS THAT ARE, OR MAY BE DEEMED, FORWARD-LOOKING STATEMENTS, WHICH RELATE, INTER ALIA, TO THE COMPANY'S PROPOSED STRATEGY, PLANS AND OBJECTIVES. SUCH FORWARD-LOOKING STATEMENTS INVOLVE KNOWN AND UNKNOWN RISKS, UNCERTAINTIES AND OTHER IMPORTANT FACTORS BEYOND THE…

NetScientific to increase Q-Bot stake to 23.7%

Jun 17, 2022
-
News, RNS Announcements
RNS REACH NetScientific plc ("NetScientific", the "Group" or the "Company") NetScientific to increase Q-Bot stake to 23.7%   NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group announces that EMV Capital, its wholly-owned subsidiary, has agreed to acquire (either itself or using a nominee) a further stake in Q-Bot of 1,066 ordinary shares (3.13%) for a total consideration of…

Q-Bot Limited (“Q-Bot”) secures £1.6m of investment to fund growth

Jun 15, 2022
-
News, RNS Announcements
NetScientific plc (“NetScientific”, the “Group” or the “Company”) Q-Bot Limited (“Q-Bot”) secures £1.6m of investment to fund growth   NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group announces that portfolio company Q-Bot has successfully closed a £1.62m investment round to fund the next stage of its growth. The additional funds will allow Q-Bot to accelerate the rollout…

Notice of AGM and Annual Report & Accounts

Jun 7, 2022
-
News, RNS Announcements
NetScientific plc (“NetScientific” or the “Company”) Notice of AGM and Annual Report & Accounts     London, UK – 07 June 2022 – NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation group, announces that in accordance with AIM Rules 20 and 26 the Group’s Annual Report and Accounts for the year ended 31 December 2021 and Notice of…

PDS Biotechnology Granted FDA Fast Track Designation for Lead Candidate PDS0101

Jun 6, 2022
-
News, RNS Announcements
06 June 2022 NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotechnology Granted FDA Fast Track Designation for Lead Candidate PDS0101 NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), has been granted Fast Track designation for PDS0101 in combination with Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), for…

PDS Biotech presents new data for two ongoing clinical trials

May 27, 2022
-
News, RNS Announcements
  NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech presents new data for two ongoing clinical trials NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), has provided updates for two their ongoing Phase 2 clinical trials, ahead of presentations at the ASCO 2022 oncology research…

General Counsel Strategic Hire and Grant of Options

May 19, 2022
-
News, RNS Announcements
NetScientific plc (“NetScientific” or the “Company”) General Counsel Strategic Hire and Grant of Options   NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation group, is delighted to announce the appointment of its first General Counsel, Ed Hooper, with immediate effect. Ed also joins as Group Company Secretary and as Executive Director to the Company's corporate finance specialist subsidiary,…
Hook Group Archives - NetScientific